Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.
Amarasinghe A, Black S, Bonhoeffer J, Carvalho SM, Dodoo A, Eskola J, Larson H, Shin S, Olsson S, Balakrishnan MR, Bellah A, Lambach P, Maure C, Wood D, Zuber P, Akanmori B, Bravo P, Pombo M, Langar H, Pfeifer D, Guichard S, Diorditsa S, Hossain MS, Sato Y. Amarasinghe A, et al. Among authors: guichard s. Vaccine. 2013 Apr 18;31 Suppl 2:B108-14. doi: 10.1016/j.vaccine.2012.10.119. Vaccine. 2013. PMID: 23598471 Review.
Strengthening of causality assessment of adverse events following immunization in the WHO South East Asia and Western Pacific regions: Lessons from the 2014 SEAR inter-country workshop.
MacDonald NE, Guichard S, Amarasinghe A, Balakrishnan MR; 2014 Inter-country SEAR Workshop Participants. MacDonald NE, et al. Among authors: guichard s. Vaccine. 2015 Nov 27;33(48):6902-7. doi: 10.1016/j.vaccine.2015.01.033. Epub 2015 Jan 21. Vaccine. 2015. PMID: 25617790
Lessons on causality assessment and communications from the 2019 South-East Asia Regional (SEAR) workshop on inter-country expert review of selected Adverse Events Following Immunization (AEFI) cases.
MacDonald NE, Guichard S, Arora N, Menning L, Wilhelm E; 2019 Inter-country SEAR Workshop Participants, Communication Experts. MacDonald NE, et al. Among authors: guichard s. Vaccine. 2020 Jul 6;38(32):4924-4932. doi: 10.1016/j.vaccine.2019.09.109. Epub 2019 Oct 11. Vaccine. 2020. PMID: 31611095
Vaccine wastage in Bangladesh.
Guichard S, Hymbaugh K, Burkholder B, Diorditsa S, Navarro C, Ahmed S, Rahman MM. Guichard S, et al. Vaccine. 2010 Jan 8;28(3):858-63. doi: 10.1016/j.vaccine.2009.08.035. Epub 2009 Aug 27. Vaccine. 2010. PMID: 19716458
Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
Bizollon T, Ahmed SN, Radenne S, Chevallier M, Chevallier P, Parvaz P, Guichard S, Ducerf C, Baulieux J, Zoulim F, Trepo C. Bizollon T, et al. Among authors: guichard s. Gut. 2003 Feb;52(2):283-7. doi: 10.1136/gut.52.2.283. Gut. 2003. PMID: 12524414 Free PMC article. Clinical Trial.
FT-4202, a selective pyruvate kinase R activator for sickle cell disease.
Ericsson A, Richard DJ, Wilker E, Lancia DR Jr, Fessler S, Troccolo P, Zheng X, Toms A, Dinsmore C, Yao L, Kuypers FA, Larkin S, Marcotte D, Fulzele K, Ribadeneira M, Guichard SM, Marshall G. Ericsson A, et al. Among authors: guichard sm. Exp Hematol. 2025 Jan;141:104673. doi: 10.1016/j.exphem.2024.104673. Epub 2024 Nov 15. Exp Hematol. 2025. PMID: 39549740 Free article.
119 results